Integer Holdings Return on Tangible Equity 2010-2025 | ITGR
Current and historical return on tangible equity values for Integer Holdings (ITGR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Integer Holdings Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $0.08B | $-0.33B | -29.96% |
| 2024-12-31 | $0.12B | $-0.18B | -45.98% |
| 2024-09-30 | $0.11B | $-0.22B | -40.29% |
| 2024-06-30 | $0.11B | $-0.30B | -34.97% |
| 2024-03-31 | $0.10B | $-0.35B | -31.69% |
| 2023-12-31 | $0.09B | $-0.26B | -28.37% |
| 2023-09-30 | $0.08B | $-0.30B | -23.45% |
| 2023-06-30 | $0.07B | $-0.34B | -18.57% |
| 2023-03-31 | $0.07B | $-0.38B | -16.51% |
| 2022-12-31 | $0.07B | $-0.39B | -16.31% |
| 2022-09-30 | $0.07B | $-0.43B | -17.87% |
| 2022-06-30 | $0.08B | $-0.46B | -21.99% |
| 2022-03-31 | $0.09B | $-0.35B | -27.92% |
| 2021-12-31 | $0.10B | $-0.38B | -32.50% |
| 2021-09-30 | $0.09B | $-0.23B | -30.29% |
| 2021-06-30 | $0.10B | $-0.27B | -29.38% |
| 2021-03-31 | $0.07B | $-0.31B | -18.31% |
| 2020-12-31 | $0.08B | $-0.35B | -19.10% |
| 2020-09-30 | $0.07B | $-0.38B | -16.85% |
| 2020-06-30 | $0.07B | $-0.43B | -16.20% |
| 2020-03-31 | $0.11B | $-0.44B | -22.47% |
| 2019-12-31 | $0.10B | $-0.46B | -19.43% |
| 2019-09-30 | $0.11B | $-0.47B | -21.15% |
| 2019-06-30 | $0.20B | $-0.51B | -34.39% |
| 2019-03-31 | $0.18B | $-0.55B | -28.99% |
| 2018-12-31 | $0.17B | $-0.58B | -22.80% |
| 2018-09-30 | $0.20B | $-0.62B | -24.71% |
| 2018-06-30 | $0.10B | $-0.75B | -10.53% |
| 2018-03-31 | $0.08B | $-0.99B | -7.85% |
| 2017-12-31 | $0.07B | $-0.81B | -6.39% |
| 2017-09-30 | $0.02B | $-1.10B | -1.84% |
| 2017-06-30 | $0.02B | $-1.13B | -1.54% |
| 2017-03-31 | $0.01B | $-1.16B | -1.17% |
| 2016-12-31 | $0.01B | $-1.18B | -0.41% |
| 2016-09-30 | $-0.03B | $-1.20B | 2.33% |
| 2016-06-30 | $-0.04B | $-1.23B | 4.60% |
| 2016-03-31 | $-0.03B | $-1.23B | 5.94% |
| 2015-12-31 | $-0.01B | $-1.15B | 6.04% |
| 2015-09-30 | $0.03B | $0.22B | 15.70% |
| 2015-06-30 | $0.05B | $0.21B | 24.76% |
| 2015-03-31 | $0.05B | $0.19B | 28.87% |
| 2014-12-31 | $0.06B | $0.17B | 36.73% |
| 2014-09-30 | $0.05B | $0.15B | 38.86% |
| 2014-06-30 | $0.05B | $0.15B | 42.48% |
| 2014-03-31 | $0.05B | $0.13B | 50.83% |
| 2013-12-31 | $0.04B | $0.10B | 53.43% |
| 2013-09-30 | $0.02B | $0.08B | 41.58% |
| 2013-06-30 | $0.00B | $0.06B | 5.59% |
| 2013-03-31 | $0.00B | $0.04B | -14.95% |
| 2012-12-31 | $-0.01B | $0.02B | -30.38% |
| 2012-09-30 | $0.01B | $0.02B | 38.10% |
| 2012-06-30 | $0.02B | $0.02B | 81.55% |
| 2012-03-31 | $0.03B | $0.01B | 77.04% |
| 2011-12-31 | $0.03B | $0.01B | 82.93% |
| 2011-09-30 | $0.04B | $0.06B | 93.33% |
| 2011-06-30 | $0.04B | $0.05B | 130.16% |
| 2011-03-31 | $0.04B | $0.04B | 242.42% |
| 2010-12-31 | $0.03B | $0.02B | 2266.67% |
| 2010-09-30 | $0.02B | $0.01B | -160.00% |
| 2010-06-30 | $-0.01B | $-0.01B | 37.11% |
| 2010-03-31 | $-0.01B | $-0.02B | 33.61% |
| 2009-12-31 | $-0.01B | $-0.03B | 25.53% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $4.182B | $1.717B |
| Integer Holdings Corporation manufactures and develops medical devices and components primarily for original equipment manufacturers, which depend on it to design, develop and produce intellectual property protected medical device technologies. Integer Holdings operates through two segments: Medical Sales and Non-Medical Sales. Medical Sales has three sub-segments Advanced Surgical, Orthopedics and Portable Medical; Cardio and Vascular; and Cardiac Rhythm Management & Neuromodulation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $197.793B | 86.63 |
| Thermo Fisher Scientific (TMO) | United States | $150.971B | 18.26 |
| Edwards Lifesciences (EW) | United States | $45.591B | 29.89 |
| IDEXX Laboratories (IDXX) | United States | $42.288B | 48.60 |
| Alcon (ALC) | Switzerland | $42.138B | 28.48 |
| DexCom (DXCM) | United States | $34.031B | 52.60 |
| IQVIA Holdings (IQV) | United States | $24.701B | 13.84 |
| Mettler-Toledo (MTD) | United States | $24.242B | 28.83 |
| STERIS (STE) | Ireland | $23.937B | 26.36 |
| Waters (WAT) | United States | $20.792B | 29.34 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.231B | 0.00 |
| Hologic (HOLX) | United States | $14.048B | 15.26 |
| Sysmex ADR (SSMXY) | Japan | $10.336B | 29.32 |
| Penumbra (PEN) | United States | $9.967B | 78.22 |
| Masimo (MASI) | United States | $8.883B | 32.77 |
| Globus Medical (GMED) | United States | $8.082B | 19.26 |
| Glaukos (GKOS) | United States | $5.399B | 0.00 |
| Teleflex (TFX) | United States | $5.366B | 8.86 |
| TransMedics (TMDX) | United States | $4.355B | 94.66 |
| PROCEPT BioRobotics (PRCT) | United States | $3.319B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.405B | 14.32 |
| Veracyte (VCYT) | United States | $2.075B | 29.12 |
| Nihon Kohden (NHNKY) | Japan | $2.022B | 23.20 |
| Elekta AB (EKTAY) | Sweden | $1.956B | 17.59 |
| Alphatec Holdings (ATEC) | United States | $1.851B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.374B | 0.00 |
| Artivion (AORT) | United States | $1.215B | 113.80 |
| Pulse Biosciences (PLSE) | United States | $1.186B | 0.00 |
| OPKO Health (OPK) | United States | $1.094B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.013B | 5.39 |
| SiBone (SIBN) | United States | $0.805B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.779B | 0.00 |
| IRadimed (IRMD) | United States | $0.760B | 38.57 |
| RxSight (RXST) | United States | $0.642B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.576B | 8.96 |
| Delcath Systems (DCTH) | United States | $0.560B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.546B | 12.80 |
| AxoGen (AXGN) | United States | $0.517B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.496B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.445B | 0.00 |
| NeuroPace (NPCE) | United States | $0.444B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.432B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.397B | 10.56 |
| Treace Medical Concepts (TMCI) | United States | $0.365B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.354B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.315B | 0.00 |
| Neuronetics (STIM) | United States | $0.254B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.239B | 14.48 |
| 908 Devices (MASS) | United States | $0.237B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.208B | 0.00 |
| CVRx (CVRX) | United States | $0.176B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.175B | 0.00 |
| Inogen (INGN) | United States | $0.172B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.163B | 0.00 |
| Accuray (ARAY) | United States | $0.162B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.161B | 0.00 |
| LENSAR (LNSR) | United States | $0.160B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.099B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.087B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.30 |
| InspireMD (NSPR) | United States | $0.078B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.028B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.19 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |